SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on May 15, 2025, reporting events occurring as of May 14, 2025. The company is incorporated in Delaware and its common stock trades on The NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report addresses a regulatory compliance event rather than financial performance.
Material Changes and Events
- Listing Deficiency: On April 11, 2025, the Nasdaq Listing Qualifications staff notified the Company that its common stock failed to maintain the minimum bid price of $1.00 over the previous 30 consecutive business days.
- Regained Compliance: The Company's closing bid price remained at or above $1.00 per share for the 10 consecutive business days from April 30, 2025, to May 13, 2025.
- Resolution: The Company has regained compliance with Listing Rule 5550(a)(2), and the matter is now closed.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or new risks. The primary risk addressed was the potential delisting due to low stock price, which has been resolved as of the report date.
Investor Verification Checklist
- Verify the current trading price of BSGM to ensure it remains above the $1.00 threshold.
- Confirm the company's status on the Nasdaq Capital Market to ensure no new deficiency notices have been issued.
- Review recent 10-Q or 10-K filings for actual financial performance data, as this 8-K contains none.